Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CORRELATE-UK: COnsistency of Response With RimegEpant Oral Lyophilisate in Acute Treatment of migrainE in the United Kingdom

NCT06898047 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT06898047
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06898047 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CORRELATE-UK: COnsistency of Response With RimegEpant Oral Lyophilisate in Acute Treatment of migrainE in the United Kingdom
Lead sponsor
Pfizer
Phase
Observational
Overall status
Active, not recruiting
Start date
November 15, 2025
Completion date
October 31, 2026
Enrollment
250 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

migraine